NeoStem Inc (NASDAQ:NBS)

6.86
Data as of 3:59pm ET
 -0.04 / -0.58%
Today’s Change
5.00
Today|||52-Week Range
9.89
+0.59%
Year-to-Date
SECTOR
Distribution Services
INDUSTRY
Wholesale Distributors
MARKET CAP
$194.4M

Company Description

NeoStem, Inc. is a biopharmaceutical company. It develops and builds core capabilities in cell therapy to capitalize on the paradigm shift. The company anticipates that cell therapy will have a large role in the fight against chronic disease and in lessening the economic burden that these diseases pose to modern society. The company operates through three segments: Cell Therapy-United States, Regenerative Medicine-China and Pharmaceutical Manufacturing-China. The Cell Therapy-United States segment is focused on the development of proprietary cellular therapies in cardiovascular disease, immunology and regenerative medicine and becoming a single source for collection, storage, manufacturing, therapeutic development and transportation of cells for cell based medicine and regenerative science. Within this segment, the company provides adult stem cell collection, processing and storage services in the U.S., enabling healthy individuals to donate and store their stem cells for personal therapeutic use. The Regenerative Medicine-China segment initiatives including: constructing a stem cell research and development laboratory and processing and manufacturing facility in Beijing, establishing relationships with hospitals to provide stem cell-based therapies, and obtaining product licenses covering certain adult stem cell therapeutics focused on regenerative medicine. The Pharmaceutical Manufacturing-China provides clinical development efforts on products under development. The company was founded in September 1980 and is headquartered in New York, NY.

Contact Information

NeoStem, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 584-4180
Investor Relations:
(212) 584-4174

Employees

Shareholders

Other institutional5.79%
Mutual fund holders3.25%
Individual stakeholders11.60%

Top Executives

Robin L. SmithChairman, CEO & Head-Investor Relations
Robert DickeyChief Financial Officer
Douglas W. LosordoChief Medical Officer
Robert A. PretiChief Scientific Officer
Timothy C. FongVice President-Technology & Product Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.